Ro64-6198

Ro64-6198 is a drug that was developed by Hoffmann-La Roche and acts as a potent and selective agonist for the nociceptin receptor, also known as the ORL-1 receptor. It has analgesic effects and has been researched for potential use in the treatment of anxiety and depression.

Pharmacology

Ro64-6198 is a potent and selective agonist for the nociceptin receptor, which is a G protein-coupled receptor that is involved in the regulation of pain and mood. The drug has been shown to have analgesic effects in animal studies, and it has also been found to have anxiolytic and antidepressant effects.

Clinical significance

The nociceptin receptor is a potential target for the treatment of various conditions, including pain, anxiety, and depression. Ro64-6198 has been researched for potential use in these areas, although it has not yet been approved for medical use.

See also

• Nociceptin receptor
• Hoffmann-La Roche
• Agonist
• Analgesic
• Anxiety
• Depression

References

Ro64-6198 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski